You are here

  • Home
  • Archive
  • Volume 11, Issue 2
  • Cost-effectiveness analysis of percutaneous coronary intervention for single-vessel coronary artery disease: an economic evaluation of the ORBITA trial

Article info

Article menu
XML
Original research
Cost-effectiveness analysis of percutaneous coronary intervention for single-vessel coronary artery disease: an economic evaluation of the ORBITA trial

Authors

  • Victoria McCreanor Australian Centre for Health Services Innovation (AusHSI) and Centre for Healthcare Transformation, Queensland University of Technology (QUT), Brisbane, Queensland, AustraliaJamieson Trauma Institute, Royal Brisbane and Women’s Hospital, Metro North Hospital and Health Service, Herston, Queensland, Australia PubMed articlesGoogle scholar articles
  • Alexandra Nowbar National Heart and Lung Institute, Imperial College London, London, UKImperial College Healthcare NHS Trust, London, UK PubMed articlesGoogle scholar articles
  • Christopher Rajkumar National Heart and Lung Institute, Imperial College London, London, UKImperial College Healthcare NHS Trust, London, UK PubMed articlesGoogle scholar articles
  • Adrian G Barnett Australian Centre for Health Services Innovation (AusHSI) and Centre for Healthcare Transformation, Queensland University of Technology (QUT), Brisbane, Queensland, Australia PubMed articlesGoogle scholar articles
  • Darrel Francis National Heart and Lung Institute, Imperial College London, London, UKImperial College Healthcare NHS Trust, London, UK PubMed articlesGoogle scholar articles
  • Nicholas Graves Health Services and Systems Research, Duke-NUS Medical School, Singapore PubMed articlesGoogle scholar articles
  • William E Boden Boston University School of Medicine, Boston, Massachusetts, USAHarvard Medical School, Boston, Massachusetts, USAVA New England Healthcare System, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • William S Weintraub Georgetown University, Washington, District of Columbia, USAMedStar Washington Hospital Center, Washington, District of Columbia, USA PubMed articlesGoogle scholar articles
  • Rasha Al-Lamee National Heart and Lung Institute, Imperial College London, London, UKImperial College Healthcare NHS Trust, London, UK PubMed articlesGoogle scholar articles
  • William A Parsonage Australian Centre for Health Services Innovation (AusHSI) and Centre for Healthcare Transformation, Queensland University of Technology (QUT), Brisbane, Queensland, AustraliaCardiology, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia PubMed articlesGoogle scholar articles
  1. Correspondence to Professor William A Parsonage; w.parsonage{at}mac.com
View Full Text

Citation

McCreanor V, Nowbar A, Rajkumar C, et al
Cost-effectiveness analysis of percutaneous coronary intervention for single-vessel coronary artery disease: an economic evaluation of the ORBITA trial
BMJ Open 2021;11:e044054. doi: 10.1136/bmjopen-2020-044054

Publication history

  • Received September 7, 2020
  • Accepted January 10, 2021
  • First published February 9, 2021.
Online issue publication 
March 16, 2023
Previous versions
Review history

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.